stockrow
Friday 6 November 2026
Export MBX’s income statement to Excel — free account
MBX Biosciences, Inc.
- EPS
- −34.5%
- Free cash flow
- −29.7%
Quarter to June 2026, against a year earlier
51.13
2.67
+5.51%
Follow MBX
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (33.17%) | (25.73%) | (27.76%) | (24.43%) |
+8 more TTM periods Free account |
|
| (31.25%) | (24.79%) | (26.61%) | (23.59%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(25.51%) | (19.81%) | (23.58%) | (20.78%) | |
Free Cash Flow per Share |
(1.79) | (1.71) | (2.24) | (2.31) | |
Free Cash Flow |
(85.20) | (79.81) | (81.88) | (78.91) | |
Capital Expenditures |
(2.53) | (2.34) | (1.93) | (1.23) | |
| Other line items | |||||
Cash ROIC |
(10.29%) | (9.09%) | (11.02%) | (10.13%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.79 | 0.89 | 0.92 | 0.97 | |
Depreciation/Fixed assets |
0.05 | 0.08 | 0.09 | 0.12 | |
Capex/Depreciation |
(10.00) | (9.94) | (7.78) | (4.99) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.73) | (1.66) | (2.19) | (2.27) | |
Capex per Share |
(0.05) | (0.05) | (0.05) | (0.04) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates